-
521
-
522
Interleukin 15‐Presenting Nanovesicles with Doxorubicin‐Loaded Ferritin Cores for Cancer Immunochemotherapy
Published 2025-01-01Subjects: Get full text
Article -
523
Single-cell landscape of dynamic changes in CD8+ T cells, CD4+ T cells and exhausted T cells in hepatocellular carcinoma
Published 2025-02-01Subjects: Get full text
Article -
524
Atezolizumab plus bevacizumab in patients with unresectable or metastatic mucosal melanoma: 3‐year survival update and multi‐omics analysis
Published 2025-01-01Subjects: Get full text
Article -
525
Pre-injection of exosomes can significantly suppress ovarian cancer growth by activating the immune system in mice
Published 2025-02-01Subjects: Get full text
Article -
526
The lysosome-related characteristics affects the prognosis and tumor microenvironment of lung adenocarcinoma
Published 2025-01-01Subjects: Get full text
Article -
527
DNA vaccines as promising immuno-therapeutics against cancer: a new insight
Published 2025-01-01Subjects: Get full text
Article -
528
Pembrolizumab as first-line treatment for recurrent and metastatic head and neck cancer – real-world single-centre data
Published 2025-01-01Subjects: “…Immunotherapy…”
Get full text
Article -
529
The therapeutic potential of bacterial lysates: applications and future perspectives
Published 2024-12-01Subjects: Get full text
Article -
530
The effect of GM-CSF and predictors of treatment outcome in pediatric septic shock patients
Published 2025-02-01Subjects: Get full text
Article -
531
-
532
The role of interleukin-17 in inflammation-related cancers
Published 2025-01-01Subjects: Get full text
Article -
533
-
534
-
535
-
536
The role of endothelial cell-related gene COL1A1 in prostate cancer diagnosis and immunotherapy: insights from machine learning and single-cell analysis
Published 2025-01-01“…Abstract Background Endothelial cells are integral components of the tumor microenvironment and play a multifaceted role in tumor immunotherapy. Targeting endothelial cells and related signaling pathways can improve the effectiveness of immunotherapy by normalizing tumor blood vessels and promoting immune cell infiltration. …”
Get full text
Article -
537
-
538
Analysis of tumor-infiltrating exhausted T cells highlights IL-6 and PD1 blockade as a combined immunotherapy strategy for non-small cell lung cancer
Published 2025-02-01“…ObjectiveGiven the limitations of immunotherapy for treating non-small cell lung cancer (NSCLC), we investigated the phenotype and function of exhausted CD8+T cells and analyzed a novel combination immunotherapy to restore the effector killing function of tumor-infiltrating CD8+T lymphocyte (TIL).MethodsWe examined the expression and function of immunosuppressive molecules on CD8+T cells of peripheral blood mononuclear cells (PBMCs) and TILs by using prospectively collected peripheral blood, pleural effusions, and tumor tissues from patients with NSCLC and correlated the results with clinical data. …”
Get full text
Article -
539
-
540
Correction: Virtual clinical trials of anti-PD-1 and anti-CTLA-4 immunotherapy in advanced hepatocellular carcinoma using a quantitative systems pharmacology model
Published 2023-01-01“…Journal for ImmunoTherapy of Cancer…”
Get full text
Article